The Valley Desk

NCT06560645 · Interventional trial

A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation

Overall registry status Terminated

Phase 1

Conditions Advanced Solid Tumor, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma, Gastric Squamous Cell Carcinoma, Gastroesophageal Junction Adenocarcinoma, Gastroesophageal Junction Squamous Cell Carcinoma, Metastatic Solid Tumor, Non-small Cell Lung Carcinoma, SMARCA4 Mutation

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov